Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for rectal cancer.

D J St John1

  • 1Department of Gastroenterology, Royal Melbourne Hospital, Australia. james.stjohn@nwhcn.org.av

Hepato-Gastroenterology
|May 3, 2000
PubMed
Summary
This summary is machine-generated.

Screening for colorectal cancer, particularly using fecal occult blood testing, can significantly reduce mortality. Flexible sigmoidoscopy screening evidence is still developing, and participation rates are key to success.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profuse familial adenomatous polyposis with an adenomatous polyposis coli exon 3 mutation.

Familial cancer·2003
Same author

Yield from colonoscopic screening in people with a strong family history of common colorectal cancer.

Journal of gastroenterology and hepatology·2000
Same author

Faecal occult blood test screening for colorectal cancer--what are we waiting for?

Australian and New Zealand journal of medicine·2000
Same author

Colorectal cancer screening in general practice. A survey of current practice and attitudes in Victoria.

Australian family physician·1999
Same author

E-cadherin unlikely to be a common "low penetrance" gene for colorectal cancer.

American journal of medical genetics·1999
Same author

Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable.

Clinical chemistry·1999
Same journal

Palliative Surgery for Gastric Cancer with Gastric Outlet Obstruction or Anemia due to Tumor Bleeding.

Hepato-gastroenterology·2016
Same journal

A Novel "Artery First" Approach Allowing Safe Resection in Laparoscopic Pancreaticoduodenectomy: The Uncinate Process First Approach.

Hepato-gastroenterology·2016
Same journal

A Phase I Study of S-1 and Gemcitabine with Concurrent Radiotherapy in Patients with Non-Metastatic Advanced Pancreatic Cancer.

Hepato-gastroenterology·2016
Same journal

A Novel Approach for Endoscopic Papillary Balloon Dilation with the Guidewire Left in the Pancreatic Duct to Ensure Pancreatic Stenting.

Hepato-gastroenterology·2016
Same journal

Which Factors are Predictive for Mortality among Hospitalized Patients with Cirrhosis?

Hepato-gastroenterology·2016
Same journal

Hydrodynamics Analysis and CFD Simulation of Portal Venous System by TIPS and LS.

Hepato-gastroenterology·2016
See all related articles

Area of Science:

  • Gastroenterology and Oncology
  • Preventive Medicine

Background:

  • Rectal cancer screening remains a debated topic in clinical practice.
  • Evidence suggests that effective screening strategies can decrease cancer-related mortality.

Purpose of the Study:

  • To evaluate the impact of screening methods on colorectal cancer mortality.
  • To assess the current evidence supporting fecal occult blood testing and flexible sigmoidoscopy for colorectal cancer screening.

Main Methods:

  • Review of three randomized controlled trials utilizing fecal occult blood testing.
  • Analysis of existing evidence for flexible sigmoidoscopy screening.
  • Consideration of factors influencing screening program success, including participation and cost-effectiveness.

Related Experiment Videos

Main Results:

  • Fecal occult blood testing demonstrated a significant reduction in overall colorectal cancer mortality in randomized trials.
  • Evidence supporting flexible sigmoidoscopy screening is less robust, with definitive trial data expected in 8-10 years.
  • Screening program success is contingent upon high participation rates and cost-effective adenoma follow-up protocols.

Conclusions:

  • Fecal occult blood testing is a proven method for reducing colorectal cancer mortality.
  • Further research and evidence are needed to establish the efficacy of flexible sigmoidoscopy.
  • Optimizing participation and cost-effectiveness are critical for successful colorectal cancer screening implementation.